F&FFinancial Insights

Financial Metrics

GRDN Guardian Pharmacy Services, Inc.
Range: 2016-01-01 to 2026-04-29
Chart Range:
% Change:

Financial Statements

Grouped by statement

Income Statement

Metrics: 6

Revenue

Q: 7 | A: 2

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2023-09-30 262741000.0 USD 10-Q 2024-11-12
Quarterly 2024-03-31 275410000.0 +4.8% USD 10-Q 2025-05-12
Quarterly 2024-06-30 300037000.0 +8.9% USD 10-Q 2025-08-11
Quarterly 2024-09-30 314393000.0 +4.8% USD 10-Q 2025-11-10
Quarterly 2025-03-31 329308000.0 +4.7% USD 10-Q 2025-05-12
Quarterly 2025-06-30 344334000.0 +4.6% USD 10-Q 2025-08-11
Quarterly 2025-09-30 377427000.0 +9.6% USD 10-Q 2025-11-10
Annual 2024-12-31 1228409000.0 USD 10-K 2026-03-11
Annual 2025-12-31 1448685000.0 +17.9% USD 10-K 2026-03-11

Gross Profit

Q: 7 | A: 2

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2023-09-30 52192000.0 USD 10-Q 2024-11-12
Quarterly 2024-03-31 55101000.0 +5.6% USD 10-Q 2025-05-12
Quarterly 2024-06-30 61288000.0 +11.2% USD 10-Q 2025-08-11
Quarterly 2024-09-30 60878000.0 -0.7% USD 10-Q 2025-11-10
Quarterly 2025-03-31 64349000.0 +5.7% USD 10-Q 2025-05-12
Quarterly 2025-06-30 68146000.0 +5.9% USD 10-Q 2025-08-11
Quarterly 2025-09-30 74721000.0 +9.6% USD 10-Q 2025-11-10
Annual 2024-12-31 244371000.0 USD 10-K 2026-03-11
Annual 2025-12-31 292718000.0 +19.8% USD 10-K 2026-03-11

Operating Income

Q: 7 | A: 2

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2023-09-30 -6330000.0 USD 10-Q 2024-11-12
Quarterly 2024-03-31 7933000.0 +225.3% USD 10-Q 2025-05-12
Quarterly 2024-06-30 17005000.0 +114.4% USD 10-Q 2025-08-11
Quarterly 2024-09-30 -104613000.0 -715.2% USD 10-Q 2025-11-10
Quarterly 2025-03-31 13005000.0 +112.4% USD 10-Q 2025-05-12
Quarterly 2025-06-30 12580000.0 -3.3% USD 10-Q 2025-08-11
Quarterly 2025-09-30 16354000.0 +30.0% USD 10-Q 2025-11-10
Annual 2024-12-31 -62920000.0 USD 10-K 2026-03-11
Annual 2025-12-31 72701000.0 +215.5% USD 10-K 2026-03-11

Net Income

Q: 7 | A: 2

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2023-09-30 -6995000.0 USD 10-Q 2024-11-12
Quarterly 2024-03-31 7095000.0 +201.4% USD 10-Q 2025-11-10
Quarterly 2024-06-30 15848000.0 +123.4% USD 10-Q 2025-11-10
Quarterly 2024-09-30 -105817000.0 -767.7% USD 10-Q 2025-11-10
Quarterly 2025-03-31 9448000.0 +108.9% USD 10-Q 2025-11-10
Quarterly 2025-06-30 9030000.0 -4.4% USD 10-Q 2025-11-10
Quarterly 2025-09-30 9593000.0 +6.2% USD 10-Q 2025-11-10
Annual 2024-12-31 -71033000.0 USD 10-K 2026-03-11
Annual 2025-12-31 48958000.0 +168.9% USD 10-K 2026-03-11

EPS Basic

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed

EPS Diluted

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed

8-K Material Event Details

18 filings · 40 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

21 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value

All Transactions

Date Insider Title Type Security Shares Price Total Value Post-Tx Shares
2026-03-28 Pharmacy Investors, LLC Exercise / conversion
M · derivative
Class B Common Stock 1,413,939 1,413,939
2026-03-28 Pharmacy Investors, LLC Exercise / conversion
M
Class A Common Stock 1,413,939 2,449,867
2026-03-20 Pharmacy Investors, LLC Open-market sell
S
Class A Common Stock 827,636 $29.68 $24,566,306 1,035,928
2026-03-01 Forbes Kendall See Remarks Equity grant / award
A
Class A Common Stock 8,952 $0.00 $0 799,928
2026-02-11 Burke Fred See Remarks Equity grant / award
A · derivative
Stock Option (right to buy) 75,000 $0.00 $0 75,000
2025-12-04 Burke Fred See Remarks Equity grant / award
G
Class A Common Stock 200,000 $0.00 $0 1,511,845
2025-12-03 COSLER STEVEN D Open-market buy
P
Class A Common Stock 3,370 $29.61 $99,786 24,984
2025-09-27 Cardinal Equity Fund, L.P. Exercise / conversion
M · derivative
Class B Common Stock 471,057 942,114
2025-09-27 Cardinal Equity Fund, L.P. Exercise / conversion
M
Class A Common Stock 471,057 620,851
2025-09-27 Ackerman John Exercise / conversion
M · derivative
Class B Common Stock 471,057 942,114
2025-09-27 Ackerman John Exercise / conversion
M · derivative
Class B Common Stock 1,413,940 2,827,878
2025-09-27 Ackerman John Exercise / conversion
M
Class A Common Stock 471,057 620,851
2025-09-27 Ackerman John Exercise / conversion
M
Class A Common Stock 1,413,940 1,863,564
2025-05-28 Cardinal Equity Fund, L.P. Open-market sell
S
Class A Common Stock 50,305 $20.16 $1,014,149 149,794
2025-05-28 BINDLEY WILLIAM E Open-market sell
S
Class A Common Stock 651,454 $20.16 $13,133,313 1,939,817
2025-05-27 Cardinal Equity Fund, L.P. Open-market sell
S
Class A Common Stock 270,958 $20.16 $5,462,513 200,099
2025-05-27 BINDLEY WILLIAM E Open-market sell
S
Class A Common Stock 3,508,905 $20.16 $70,739,525 2,591,271
2025-05-09 COSLER STEVEN D Equity grant / award
A
Class A Common Stock 3,901 $0.00 $0 21,614
2025-02-05 Forbes Kendall See Remarks Equity grant / award
A
Class A Common Stock 10,385 $0.00 $0 10,385
2024-11-19 COSLER STEVEN D Open-market buy
P
Class A Common Stock 7,000 $21.22 $148,540 17,713
2024-09-27 BINDLEY WILLIAM E Equity grant / award
A · derivative
Class B Common Stock 24,400,702 24,400,702

Regulatory Activity

Last 12 months to 2025-04-29
Insider Filings (Forms 3/4/5) — 12 months
11
Material Event Filings (8-K) — 12 months
11

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count
For informational purposes only — not guaranteed to be accurate or complete.